Showing posts with label Breast cancer. Show all posts
Showing posts with label Breast cancer. Show all posts

Thursday, March 17, 2011

Odds Good for Older Women With DCIS, Early Breast Cancer

By Charles Bankhead, Staff Writer, MedPage Today

A diagnosis of ductal carcinoma in-situ (DCIS) or stage I breast cancer does not reduce survival odds for women older than 67, but diagnosis of a higher-stage malignancy does, an NIH database analysis showed.

Women with DCIS or stage I breast cancer had mortality hazards of 0.9 to 1.0 compared with age-matched women who did not have breast cancer, according to Mara A. Schonberg, MD, of Beth Israel Deaconess Medical Center in Boston, and colleagues.

However, the mortality risk increased by 50% compared with controls with a diagnosis of stage II or higher breast cancer, they reported online in the Journal of Clinical Oncology.

"More women age 67 years and older diagnosed with DCIS or stage I breast cancer and women age ≥80 years diagnosed with stage II disease die of cardiovascular disease than breast cancer," Schonberg and colleagues wrote in the discussion of their findings.
More

Friday, February 18, 2011

Late Breast Cancer Diagnosis In Elderly Leads To Poor Survival

Women over 70 are being diagnosed with breast cancer at a later stage leading to lower survival from the disease in the elderly, new research showed today (Wednesday).

The study, published in the British Journal of Cancer*, also found that older breast cancer patients were less likely to receive the same level of treatment as younger patients.

Scientists said that improving access to treatment, in particular surgery, among the elderly could significantly improve their breast cancer survival.

They found that it was also important for women to report any symptoms to their GP as soon as they noticed them and be aware they could continue to have access to screening.

The research analysed over 14,000 women diagnosed with breast cancer between 1999 and 2007 from Eastern Cancer Registration and Information Centre (ECRiC) and looked at five and ten-year survival for patients in four different age groups.**

The results showed that women diagnosed with breast cancer between 50 and 69 years had an 89 per cent chance of surviving their disease for five-years.***

However this fell to 81 per cent for women aged 70-74 years old and to 70 per cent for women over 80.

Three per cent of women in the 50-69 age group were diagnosed with breast cancer at a late stage.**** These women would have been routinely invited for a mammogram every three years through the national screening programme.

In comparison, eight per cent of women 70-74 and 10 per cent of women over 80 had a late stage diagnosis.

Women diagnosed at a late stage had a 14 per cent chance of surviving their disease for five-years.

Dr Paul Pharoah, a Cancer Research UK-funded scientist and one of the study's authors based at the University of Cambridge, said: "This study suggests that improving the way breast cancer is diagnosed and treated in the elderly could mean fewer die prematurely from the disease.

"The national breast screening programme is very good at picking up cases of breast cancer in 50-70 age group it is aimed at.

"But more needs to be done to raise awareness of the disease in older women who are not automatically invited for mammograms, especially since risk of the disease increases with age."

The research also suggested that older women did not always receive the same level of treatment for breast cancer as younger patients.

Around 96 per cent of women aged 50-69 years old had surgery for breast cancer, but this fell to around 60 per cent for women over 70.

Dr Pharoah said that factors like patient preferences, suitability and other illness could explain the differences in treatment - but only to a certain point.

He added that more detailed diagnoses of breast cancer in the elderly could ensure that older women suitable for treatments like surgery, chemotherapy and radiotherapy received them.

Sara Hiom, director of health information at Cancer Research UK, said: "We know that older people are less likely to survive breast cancer - this study highlights that many factors are at play and that late diagnosis and varying access to treatment, in particular, are playing a key role.

"Late diagnosis in the elderly could also be down to women delaying a visit to the doctor, so it's really vital that women are aware of breast cancer symptoms.

"After they turn 70, many women assume that breast cancer is less of a risk because they are no longer invited for screening but this isn't the case.

"More must be done to ensure that older women are well informed about their breast cancer risk, their option to ask for a mammogram and are consistently offered a full range of treatment options where this might benefit them.

"Further work needs to be done to understand why there are these large differences in breast cancer survival between older and younger women so that we can work to ensure that this gap is closed."

Reference

*Ali, A MG et al., Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England, British Journal of Cancer (2011)

Notes

**Four age groups were: 50-69 years-old, 70-74 years-old, 75-79 years-old and 80+

***after adjusting for the probability of dying from another illness

****Late stage is classed as stage four breast cancer. This means the cancer has spread to other organs in the body and curative treatment may no longer be possible.

Source:
Cancer Research UK
Enhanced by Zemanta

Saturday, February 12, 2011

FDA Okays First 3-D Mammogram Device

Logo of the U.S. Food and Drug Administration ...Image via Wikipedia
By Cole Petrochko, Staff Writer, MedPage Today

The FDA has approved the first x-ray mammography device that provides 3-D images of the breast.

Approval of the Selenia Dimensions System was based on two studies asking radiologists to review 2-D and/or 3-D images from over 300 mammographies. Radiologists who viewed the 2-D and 3-D models were 7% more accurate in distinguishing cancerous and noncancerous cases than those who only used a 2-D image, an FDA statement said.
Full Article
Enhanced by Zemanta

Saturday, January 29, 2011

Protein Related To Aging Holds Breast Cancer Clues

Source: Melissa Marino - Vanderbilt University Medical Center

The most common type of breast cancer in older women - estrogen and progesterone receptor (ER/PR) positive breast cancer - has been linked to a protein that fends off aging-related cellular damage.

A new study led by Vanderbilt-Ingram Cancer Center researcher David Gius, M.D., Ph.D., now shows how a deficiency in this aging-associated protein may set the stage for these tumors to develop.

The findings, published in Molecular Cell, provide information that could assist in the screening, prevention and treatment of these common age-related cancers.

While the young are certainly not spared cancer's wrath, cancer is primarily a disease of aging, with the majority of cases occurring in people over 50.
Full Article
Enhanced by Zemanta

Monday, October 11, 2010

Older Women Too Can Benefit from Trastuzumab - in Meeting Coverage, ESMO from MedPage Today

By Ed Susman, Contributing Writer, MedPage Today

MILAN -- Women in their 70s and 80s diagnosed with metastatic breast cancer appear to benefit from treatment with trastuzumab (Herceptin), researchers reported at the European Society for Medical Oncology Conference.
Full Article
Enhanced by Zemanta

Monday, October 4, 2010

All Cancer Therapies May Impair Memory from MedPage Today

By Ed Susman, Contributing Writer, MedPage Today

Cognitive impairments associated with breast cancer treatment are not limited only to "chemobrain," but may occur with radiation or hormonal therapies as well, a researcher said here.

About 14% of individuals who had undergone therapy for a variety of cancer diagnoses complained of post-therapy memory loss compared with 8% of individuals who had not received cancer treatments (P=0.001),

"Chemobrain is sort of a misnomer, because we observed this memory-loss phenomenon among people who have undergone chemotherapy, radiation therapy or hormonal therapy for treatment of various types of cancer," Jean-Pierre told MedPage Today during a poster session here at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities.
Full Article
Enhanced by Zemanta

Tuesday, September 14, 2010

Cognitive Effects of Breast Cancer Tx Related to Age from MedPage Today

By Charles Bankhead, Staff Writer, MedPage Today

Chemotherapy-related cognitive changes had significant associations with older age and lower baseline cognitive reserve, data from a case-control study of breast cancer patients showed.

Older patients with lower cognitive reserve who were treated with chemotherapy scored significantly lower on tests of processing speed than women treated only with tamoxifen (P=0.003) and a healthy control group (P<0.001),>Journal of Clinical Oncology.

Chemotherapy also appeared to have a temporary adverse effect on verbal ability, which differed significantly from the tamoxifen-only and control groups at one month (P=0.01). Verbal ability improved, however, during two subsequent follow-up evaluations of patients who received chemotherapy.

The findings suggest that pretreatment factors, as well as various aspects of breast cancer and its therapy, have an impact on cognitive functioning, the researchers wrote.
Full Article
Enhanced by Zemanta

Tuesday, July 13, 2010

Vital Signs: Breast Cancer Screening Among Women Aged 50--74 Years --- United States, 2008

Logo of the Centers for Disease Control and Pr...Image via Wikipedia
Breast cancer remains the second leading cause of cancer deaths for women in the United States. Screening with treatment has lowered breast cancer mortality.

In recent years, mammography rates have plateaued. Critical gaps in screening remain for certain racial/ethnic groups and lower socioeconomic groups, and for the uninsured.

Continue Reading
Enhanced by Zemanta

Wednesday, July 7, 2010

How to Encourage Repeat Mammograms? Are Interventions Worth the Effort, Money?

by Nick Mulcahy

A meta-analysis of public health interventions that promote repeat mammography was unable to identify which interventions were most effective.

The interventions to encourage women to regularly receive screening on a 1- or 2-year schedule include reminder systems, educational outreach, and intensive counseling.

An editorial accompanying the analysis, both of which were published online June 29 in the Journal of the National Cancer Institute, described the results as "sobering."

"Behavioral interventions only increase rates by a small to moderate amount, and there is insufficient evidence to know which approaches are most effective," write editorialists Jeanne Mandelblatt, MD, MPH, and Diana Buist, PhD, from the Cancer Control Program at Georgetown University Medical Center in Washington, DC.
Continue Reading
Enhanced by Zemanta

Vital Signs: Breast Cancer Screening Among Women Aged 50--74 Years --- United States, 2008

Logo of the Centers for Disease Control and Pr...Image via Wikipedia
Breast cancer remains the most commonly diagnosed cancer and the second leading cause of cancer deaths among women in the United States. In 2006 (the most recent data available), approximately 191,410 women were diagnosed with invasive breast cancer, and 40,820 women died (1). The incidence and mortality have been declining since 1996 at a rate of approximately 2% per year (2), possibly as a result of widespread screening with mammography and the development of more effective therapies (3). Mammography use declined slightly in 2004, but rose again in 2006 (4,5). This Vital Signs report updates mammography screening prevalence in the United States, using data from the 2008 Behavioral Risk Factor Surveillance System (BRFSS).
Read More
Enhanced by Zemanta